Koliaki C, Liatis S, Kokkinos A. Obesity and cardiovascular disease: revisiting an old relationship. Metabolism. 2019;92:98–107. https://doi.org/10.1016/j.metabol.2018.10.011.
Article CAS PubMed Google Scholar
Bhupathiraju SN, Hu FB. Epidemiology of obesity and diabetes and their cardiovascular complications. Circ Res. 2016;118(11):1723–35. https://doi.org/10.1161/CIRCRESAHA.115.306825.
Article CAS PubMed PubMed Central Google Scholar
Zorena K, Jachimowicz-Duda O, Ślęzak D, et al. Adipokines and obesity. potential link to metabolic disorders and chronic complications. Int J Mol Sci. 2020;21(10):3570. https://doi.org/10.3390/ijms21103570.
Wolfe BM, Kvach E, Eckel RH. Treatment of obesity: weight loss and bariatric surgery. Circ Res. 2016;118(11):1844–55. https://doi.org/10.1161/CIRCRESAHA.116.307591.
Article CAS PubMed PubMed Central Google Scholar
Panteliou E, Miras AD. What is the role of bariatric surgery in the management of obesity? Climacteric. 2017;20(2):97–102. https://doi.org/10.1080/13697137.2017.1262638.
Article CAS PubMed Google Scholar
Sundbom M. Laparoscopic revolution in bariatric surgery. World J Gastroenterol. 2014;20(41):15135–43.
Article PubMed PubMed Central Google Scholar
Pouwels S, Buise MP, Twardowski P, et al. Obesity surgery and anesthesiology risks: a review of key concepts and related physiology. Obes Surg. 2019;29(8):2670–7. https://doi.org/10.3748/wjg.v20.i41.15135.
Smit C, De Hoogd S, Brüggemann RJM, et al. Obesity and drug pharmacology: a review of the influence of obesity on pharmacokinetic and pharmacodynamic parameters. Expert Opin Drug Metab Toxicol. 2018;14(3):275–85. https://doi.org/10.1080/17425255.2018.1440287.
Article CAS PubMed Google Scholar
Dong D, Peng X, Liu J, et al. Morbid obesity alters both pharmacokinetics and pharmacodynamics of propofol: dosing recommendation for anesthesia induction. Drug Metab Dispos. 2016;44(10):1579–83. https://doi.org/10.1124/dmd.116.071605.
Article CAS PubMed Google Scholar
Jung D, Mayersohn M, Perrier D, et al. Thiopental disposition in lean and obese patients undergoing surgery. Anesthesiology. 1982;56(4):269–74. https://doi.org/10.1097/00000542-198204000-00007.
Article CAS PubMed Google Scholar
Hung KC, Chang YJ, Chen IW, et al. Efficacy of intraoperative intravenous lidocaine for postoperative analgesia following bariatric surgery: a meta-analysis of randomized controlled studies. Surg Obes Relat Dis. 2022;18(1):135–47. https://doi.org/10.1016/j.soard.2021.08.014.
Sakata RK, de Lima RC, Valadao JA, et al. Randomized, double-blind study of the effect of intraoperative intravenous lidocaine on the opioid consumption and criteria for hospital discharge after bariatric surgery. Obes Surg. 2020;30(4):1189–93. https://doi.org/10.1007/s11695-019-04340-2.
Kranke P, Jokinen J, Pace NL, et al. Continuous intravenous perioperative lidocaine infusion for postoperative pain and recovery. Cochrane Database Syst Rev. 2015;7:Cd009642. https://doi.org/10.1002/14651858.CD009642.pub2.
Sun J, Wang S, Wang J, et al. Effect of Intravenous Infusion of Lidocaine Compared with Ultrasound-Guided Transverse Abdominal Plane Block on the Quality of Postoperative Recovery in Patients Undergoing Laparoscopic Bariatric Surgery. Drug Des Devel Ther. 2022;16:739–48. https://doi.org/10.2147/DDDT.S356880.
Article CAS PubMed PubMed Central Google Scholar
Gallagher D, DeLegge M. Body composition (sarcopenia) in obese patients: implications for care in the intensive care unit. JPEN J Parenter Enteral Nutr. 2011;35(5 Suppl):21S-S28. https://doi.org/10.1177/0148607111413773.
Article PubMed PubMed Central Google Scholar
Abernethy DR, Greenblatt DJ. Lidocaine disposition in obesity. Am J Cardiol. 1984;53(8):1183–6. https://doi.org/10.1016/0002-9149(84)90659-3.
Article CAS PubMed Google Scholar
Gouju J, Legeay S. Pharmacokinetics of obese adults: Not only an increase in weight. Biomed Pharmacother. 2023;166: 115281. https://doi.org/10.1016/j.biopha.2023.115281.
Article CAS PubMed Google Scholar
Hebbes CP, Thompson JP. Pharmacokinetics of anaesthetic drugs at extremes of body weight. BJA Educ. 2018;18(12):364–70. https://doi.org/10.1016/j.bjae.2018.09.001.
Article CAS PubMed PubMed Central Google Scholar
Li X, Lv X, Jiang Z, Nie X, Wang X, Li T, Zhang L, Liu S. Application of intravenous lidocaine in obese patients undergoing painless colonoscopy: a prospective, randomized, double-blind, controlled study. Drug Des Devel Ther. 2020;27(14):3509–18. https://doi.org/10.2147/DDDT.S266062.
De Oliveira GS, Duncan K, Fitzgerald P, et al. Systemic lidocaine to improve quality of recovery after laparoscopic bariatric surgery: a randomized double-blinded placebo-controlled trial. Obes Surg. 2014;24(2):212–8. https://doi.org/10.1007/s11695-013-1077-x.
Bill TJ, Clayman MA, Morgan RF, et al. Lidocaine metabolism pathophysiology, drug interactions, and surgical implications. Aesthet Surg J. 2004;24(4):307–11. https://doi.org/10.1016/j.asj.2004.05.001.
Narang PK, Crouthamel WG, Carliner NH, et al. Lidocaine and its active metabolites. Clin Pharmacol Ther. 1978;24(6):654–62. https://doi.org/10.1002/cpt1978246654.
Article CAS PubMed Google Scholar
Jin Y, He C, Di X, et al. Simultaneous determination of lidocaine and its active metabolites in plasma by UPLC-MS/MS and application to a clinical pharmacokinetic study in liver cancer patients with laparoscopic hepatectomy. J Chromatogr B Analyt Technol Biomed Life Sci. 2022;1207: 123362. https://doi.org/10.1016/j.jchromb.2022.123362.
Article CAS PubMed Google Scholar
Xu G, Qiao N, Pan Y, Simayi A, Chen N. The appropriate dose of propofol for anesthesia induction in morbidly obese patients. Ann Palliat Med. 2020;9(4):1921–7. https://doi.org/10.21037/apm-20-1223.
Dong D, Peng X, Liu J, Qian H, Li J, Wu B. Morbid obesity alters both pharmacokinetics and pharmacodynamics of propofol: dosing recommendation for anesthesia induction. Drug Metab Dispos. 2016;44(10):1579–83. https://doi.org/10.1124/dmd.116.071605.
Article CAS PubMed Google Scholar
Meyhoff CS, Lund J, Jenstrup MT, Claudius C, Sørensen AM, Viby-Mogensen J, Rasmussen LS. Should dosing of rocuronium in obese patients be based on ideal or corrected body weight? Anesth Analg. 2009;109(3):787–92. https://doi.org/10.1213/ane.0b013e3181b0826a.
Article CAS PubMed Google Scholar
The Food and Drug Administration (2018) Bioanalytical method validation guidance for industry. https://www.fda.gov/media/70858/download. Accessed 3 May 2022
European Medicines Agency (2015) Guideline on bioanalytical method validation. https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-bioanalytical-method-validation_en.pdf. Accessed 3 May 2022
Janmahasatian S, Duffull SB, Ash S, Ward LC, Byrne NM, Green B. Quantification of lean bodyweight. Clin Pharmacokinet. 2005;44:1051–65. https://doi.org/10.2165/00003088-200544100-00004.
Laurent I, Astère M, Paul B, et al. The use of Broca index to assess cut-off points for overweight in adults: a short review. Rev Endocr Metab Disord. 2020;21:521–6. https://doi.org/10.1007/s11154-020-09566-5.
HODGMAN T. Lidocaine. In: Cohen H. eds. Casebook in Clinical Pharmacokinetics and Drug Dosing. McGraw-Hill Education; 2015. https://accesspharmacy.mhmedical.com/content.aspx?bookid=1514§ionid=88804068 Accessed 2 Mar 2024.
De Baerdemaeker LE, Mortier EP, Struys MM. Pharmacokinetics in obese patients. Continuing Education in Anaesthesia Critical Care & Pain. 2004;4(2):152–5. https://doi.org/10.1093/bjaceaccp/mkh042.
Comments (0)